Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms
Open Access
- 9 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 89 (2) , 446-456
Abstract
Human thoracic aortic aneurysms (TAAs) are characterized by extracellular matrix breakdown associated with progressive smooth muscle cell (SMC) rarefaction. These features are present in all types of TAA: monogenic forms [mainly Marfan syndrome (MFS)], forms associated with bicuspid aortic valve (BAV), and degenerative forms. Initially described in a mouse model of MFS, the transforming growth factor-β1 (TGF-β1)/Smad2 signalling pathway is now assumed to play a role in TAA of various aetiologies. However, the relation between the aetiological diversity and the common cell phenotype with respect to TGF-β signalling remains unexplained. This study was performed on human aortic samples, including TAA [MFS, n = 14; BAV, n = 15; and degenerative, n = 19] and normal aortas (n = 10) from which tissue extracts and human SMCs and fibroblasts were obtained. We show that all types of TAA share a complex dysregulation of Smad2 signalling, independent of TGF-β1 in TAA-derived SMCs (pharmacological study, qPCR). The Smad2 dysregulation is characterized by an SMC-specific, heritable activation and overexpression of Smad2, compared with normal aortas. The cell specificity and heritability of this overexpression strongly suggest the implication of epigenetic control of Smad2 expression. By chromatin immunoprecipitation, we demonstrate that the increases in H3K9/14 acetylation and H3K4 methylation are involved in Smad2 overexpression in TAA, in a cell-specific and transcription start site-specific manner. Our results demonstrate the heritability, the cell specificity, and the independence with regard to TGF-β1 and genetic backgrounds of the Smad2 dysregulation in human thoracic aneurysms and the involvement of epigenetic mechanisms regulating histone marks in this process.Keywords
This publication has 44 references indexed in Scilit:
- The role of epigenetics in the pathology of diabetic complicationsAmerican Journal of Physiology-Renal Physiology, 2010
- Circulating Transforming Growth Factor-β in Marfan SyndromeCirculation, 2009
- Regulation of TGF‐β family signaling by E3 ubiquitin ligasesCancer Science, 2008
- Transforming Growth Factor-β Signaling in Thoracic Aortic Aneurysm Development: A Paradox in PathogenesisJournal of Vascular Research, 2008
- Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetesProceedings of the National Academy of Sciences, 2008
- Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting systemProceedings of the National Academy of Sciences, 2008
- MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin IIHuman Molecular Genetics, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- The molecular genetics of Marfan syndrome and related disordersJournal of Medical Genetics, 2006
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003